Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hospital Admission
100%
Nationwide Registers
100%
Register Study
100%
Measles Virus
100%
Measles-mumps-rubella
100%
Measles-mumps-rubella Vaccine
100%
Mumps Vaccine
100%
DTaP-IPV
100%
Simultaneous Vaccination
100%
Simultaneous Administration
50%
Infectious Diseases
37%
Lower Respiratory Tract Infection
37%
Confidence Interval
25%
Denmark
25%
Incidence Rate
25%
Vaccination
25%
Live Vaccine
25%
Risk Reduction
12%
Cox Regression
12%
High Incidence
12%
Low-income Countries
12%
Child Mortality
12%
High-income Setting
12%
Inactivated Vaccine
12%
DTaP-IPV-Hib Vaccine
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Vaccination Policy
100%
Infection
100%
Measles Rubella Vaccine
100%
Measles Mumps Vaccine
100%
Lower Respiratory Tract Infection
37%
Childhood Mortality
12%
Measles Vaccine
12%
Live Vaccine
12%
Haemophilus Influenzae Type B Vaccine
12%
Inactivated Vaccine
12%
Mumps Vaccine
12%
Rubella Vaccine
12%
Medicine and Dentistry
Infection
100%
Cohort Analysis
100%
Measles Rubella Vaccine
100%
Measles Mumps Vaccine
100%
Lower Respiratory Tract Infection
37%
Proportional Hazards Model
12%
Childhood Mortality
12%
Haemophilus Influenzae Type B Vaccine
12%
Live Vaccine
12%
Measles Vaccine
12%
Inactivated Vaccine
12%
Rubella Vaccine
12%
Mumps Vaccine
12%